Evolving Adjuvant Treatments for HER2+ Early Breast Cancer - Episode 2
Vijayakrishna Gadi, MD, PhD, and Megan Kruse, MD, discuss how standard-of-care treatment has evolved for patients with HER2-positive early breast cancer.